Affinity Asset Advisors, Llc Portfolio Stock Holdings
Affinity Asset Advisors, Llc disclosed 95 stock positions valued at approximately $1.7 billion in its latest SEC 13F filing. The largest holdings include APOGEE THERAPEUTICS INC, XENON PHARMACEUTICALS INC, and ERASCA INC. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 95
- Portfolio Value
- $1.7B
Holdings by Sector
Affinity Asset Advisors, Llc Portfolio Holdings in Q1 2026
65 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC | APGE | Healthcare | 6.34% | 1,284,926 | +50,000 | +4.05% | $108,152,221 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 5.71% | 1,675,000 | +425,000 | +34.00% | $97,401,250 |
| ERASCA INC | ERAS | Healthcare | 5.08% | 5,350,000 | +1,450,000 | +37.18% | $86,563,000 |
| INSMED INC | INSM | Healthcare | 4.60% | 480,000 | +30,000 | +6.67% | $78,489,600 |
| ROIVANT SCIENCES LTD | G76279101 | Other | 4.55% | 2,800,000 | +1,100,000 | +64.71% | $77,560,000 |
| SPYRE THERAPEUTICS INC | SYRE | Healthcare | 3.78% | 1,279,134 | -153,457 | -10.71% | $64,519,519 |
| CENTESSA PHARMACEUTICALS PLC | CNTA | Healthcare | 3.26% | 1,400,000 | +799,448 | +133.12% | $55,608,000 |
| PRAXIS PRECISION MEDICINES I | PRAX | Healthcare | 3.21% | 170,000 | -15,000 | -8.11% | $54,772,300 |
| ANAPTYSBIO INC | ANAB | Healthcare | 3.06% | 940,000 | +495,308 | +111.38% | $52,132,400 |
| ALKERMES PLC | G01767105 | Other | 2.80% | 1,350,000 | +350,000 | +35.00% | $47,736,000 |
| CYTOKINETICS INC | CYTK | Healthcare | 2.71% | 700,483 | -99,517 | -12.44% | $46,168,835 |
| ABIVAX SA | ABVX | Healthcare | 2.64% | 405,000 | -100,000 | -19.80% | $45,096,750 |
| TEVA PHARMACEUTICAL INDS LTD | TEVA | Healthcare | 2.47% | 1,400,000 | - | - | $42,168,000 |
| ARCELLX INC | ACLX | Healthcare | 2.44% | 362,764 | -160,961 | -30.73% | $41,652,562 |
| NUVALENT INC | NUVL | Healthcare | 1.80% | 300,000 | -22,633 | -7.02% | $30,735,000 |
| TERNS PHARMACEUTICALS INC | TERN | Healthcare | 1.74% | 562,631 | +12,631 | +2.30% | $29,661,906 |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 1.72% | 350,000 | +235,000 | +204.35% | $29,372,000 |
| LEXEO THERAPEUTICS INC | LXEO | Healthcare | 1.70% | 5,050,211 | +1,850,211 | +57.82% | $28,988,211 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 1.69% | 750,000 | +400,000 | +114.29% | $28,867,500 |
| MADRIGAL PHARMACEUTICALS INC | MDGL | Healthcare | 1.69% | 55,000 | +23,869 | +76.67% | $28,790,850 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 1.40% | 2,000,172 | -150,000 | -6.98% | $23,862,052 |
| OVID THERAPEUTICS INC | OVID | Healthcare | 1.38% | 10,636,318 | +3,486,318 | +48.76% | $23,612,626 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 1.35% | 586,904 | +586,904 | +100.00% | $23,006,637 |
| ASCENDIS PHARMA A/S | ASND | Healthcare | 1.27% | 95,000 | +65,000 | +216.67% | $21,729,350 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 1.19% | 750,000 | +20,000 | +2.74% | $20,317,500 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 1.17% | 1,340,840 | +289,786 | +27.57% | $20,018,741 |
| PROTAGONIST THERAPEUTICS INC | PTGX | Healthcare | 1.06% | 172,125 | - | - | $18,141,975 |
| CELLDEX THERAPEUTICS INC NEW | CLDX | Healthcare | 0.93% | 500,000 | +150,000 | +42.86% | $15,860,000 |
| NURIX THERAPEUTICS INC | NRIX | Healthcare | 0.88% | 967,620 | - | - | $14,998,110 |
| SAVARA INC | SVRA | Healthcare | 0.80% | 2,512,153 | -285,000 | -10.19% | $13,716,355 |
| PERSPECTIVE THERAPEUTICS INC | CATX | Healthcare | 0.77% | 3,164,582 | +2,864,582 | +954.86% | $13,196,307 |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | Healthcare | 0.74% | 200,000 | +130,000 | +185.71% | $12,540,000 |
| ALTO NEUROSCIENCE INC | ANRO | Healthcare | 0.66% | 500,000 | +500,000 | +100.00% | $11,240,000 |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 0.65% | 150,000 | -170,000 | -53.13% | $11,139,000 |
| CULLINAN THERAPEUTICS INC | CGEM | Healthcare | 0.65% | 781,260 | -1,150,846 | -59.56% | $11,101,705 |
| BELITE BIO INC | BLTE | Healthcare | 0.61% | 65,000 | +45,000 | +225.00% | $10,363,600 |
| VERA THERAPEUTICS INC | VERA | Healthcare | 0.59% | 250,000 | - | - | $10,057,500 |
| TYRA BIOSCIENCES INC | TYRA | Healthcare | 0.58% | 257,512 | +257,512 | +100.00% | $9,862,710 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 0.57% | 100,000 | - | - | $9,725,000 |
| TRAVERE THERAPEUTICS INC | TVTX | Healthcare | 0.52% | 300,000 | - | - | $8,913,000 |
| NEWAMSTERDAM PHARMA COMPANY | NAMSW | Other | 0.52% | 275,000 | - | - | $8,802,750 |
| KORRO BIO INC | KRRO | Healthcare | 0.47% | 706,904 | +706,904 | +100.00% | $8,002,153 |
| COMPASS PATHWAYS PLC | CMPS | Healthcare | 0.36% | 1,108,483 | +908,483 | +454.24% | $6,129,911 |
| IBIO INC | IBIO | Healthcare | 0.35% | 3,107,200 | +1,050,000 | +51.04% | $5,903,680 |
| ESTABLISHMENT LABS HLDGS INC | ESTA | Other | 0.33% | 100,000 | -100,000 | -50.00% | $5,678,000 |
| VIRIDIAN THERAPEUTICS INC | VRDN | Healthcare | 0.29% | 250,000 | - | - | $4,890,000 |
| CLIMB BIO INC | ELYM | Other | 0.28% | 700,000 | -600,000 | -46.15% | $4,795,000 |
| REZOLUTE INC | RZLT | Healthcare | 0.28% | 1,547,641 | -803,503 | -34.17% | $4,720,305 |
| SAGIMET BIOSCIENCES INC | SGMT | Healthcare | 0.27% | 868,020 | -280,225 | -24.40% | $4,535,405 |
| TAYSHA GENE THERAPIES INC | TSHA | Healthcare | 0.26% | 1,000,000 | -2,300,000 | -69.70% | $4,470,000 |
| ENGENE HOLDINGS INC | ENGN | Healthcare | 0.24% | 610,370 | -33,000 | -5.13% | $4,156,620 |
| ARRIVENT BIOPHARMA INC | AVBP | Healthcare | 0.24% | 175,000 | +25,000 | +16.67% | $4,037,250 |
| RELAY THERAPEUTICS INC | RLAY | Healthcare | 0.23% | 400,000 | +400,000 | +100.00% | $3,980,000 |
| PRECISION BIOSCIENCES INC | DTIL | Healthcare | 0.19% | 597,946 | +597,946 | +100.00% | $3,288,703 |
| CRINETICS PHARMACEUTICALS IN | CRNX | Healthcare | 0.16% | 75,000 | - | - | $2,724,000 |
| IMMUNOVANT INC | IMVT | Healthcare | 0.15% | 100,000 | -100,000 | -50.00% | $2,484,000 |
| EQUILLIUM INC | EQ | Healthcare | 0.14% | 1,226,310 | +1,226,310 | +100.00% | $2,452,620 |
| SAB BIOTHERAPEUTICS INC | SABS | Healthcare | 0.13% | 575,000 | +575,000 | +100.00% | $2,202,250 |
| CORCEPT THERAPEUTICS INC | CORT | Healthcare | 0.12% | 50,000 | +50,000 | +100.00% | $2,015,500 |
| ORCHESTRA BIOMED HLDGS INC | OBIO | Healthcare | 0.10% | 402,550 | -170,254 | -29.72% | $1,710,838 |
| MACROGENICS INC | MGNX | Healthcare | 0.08% | 500,000 | +15,692 | +3.24% | $1,445,000 |
| ALECTOR INC | ALEC | Healthcare | 0.06% | 500,000 | +500,000 | +100.00% | $1,075,000 |
| LENZ THERAPEUTICS INC | LENZ | Healthcare | 0.05% | 100,000 | +100,000 | +100.00% | $915,000 |
| Q32 BIO INC | QTTB | Healthcare | 0.01% | 27,777 | - | - | $178,328 |
| ROCKET PHARMACEUTICALS INC | RCKTW | Other | 0.00% | 75,000 | - | - | $1,178 |
Affinity Asset Advisors, Llc Options Holdings in Q1 2026
8 options positions in the latest reporting period.
Page 1 of 1
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q1 2026 | SPY | SPDR S&P 500 | PUT | 200,000 | $130,068,000 |
| Q1 2026 | MRNA | Moderna, Inc. | CALL | 800,000 | $40,640,000 |
| Q1 2026 | BMY | Bristol-Myers Squibb Company | CALL | 300,000 | $18,195,000 |
| Q1 2026 | IBRX | ImmunityBio, Inc. | PUT | 1,250,000 | $9,587,500 |
| Q1 2026 | NVO | Novo Nordisk A/S | CALL | 175,000 | $6,431,250 |
| Q1 2026 | DNTH | Dianthus Therapeutics, Inc. | CALL | 50,000 | $4,196,000 |
| Q1 2026 | CGON | CG Oncology, Inc. | CALL | 60,000 | $4,060,800 |
| Q1 2026 | CELC | Celcuity Inc. | CALL | 30,000 | $3,424,200 |
Notional value represents the total exposure of the options position.